
Browsing restrictions can be lifted for a fee.
## LLY PE Stream Chart Analysis **Current Valuation (Latest Data Point):** As of the latest month (mid-March 2026), LLY's monthly average price stands at approximately **$918.05**, which places it firmly within the **Value Interval** — trading above the 26.2x PE boundary (priced at ~$603.56) but well below the 46.1x PE boundary (priced at ~$1,059.46). This positioning suggests the stock is currently in a relatively **undervalued-to-fair** zone by historical standards, sitting closer to the lower end of its PE band spectrum. The stock would need to appreciate to roughly $1,059 to reach the 46.1x threshold, representing meaningful upside before entering the **Fair Interval** (46.1x–65.9x). **Historical Trend Analysis:** Over the observed period from early 2021 through mid-March 2026, LLY's valuation trajectory has been remarkable and broadly upward-trending, reflecting significant earnings growth that has continuously re-anchored the PE river bands higher. In early 2021, the stock traded near **$180**, comfortably above the 26.2x boundary (~$179) but well below the 46.1x boundary (~$314), placing it in the **Value Interval**. Through 2021 and 2022, the price climbed steadily into the $230–$360 range, consistently remaining within the **Value Interval** as PE boundaries shifted with earnings revisions. A notable inflection occurred in mid-to-late 2023, when the stock surged from ~$320 to over **$570**, briefly approaching and occasionally testing the **Fair Interval** (46.1x–65.9x boundary), as the market began pricing in LLY's GLP-1 drug pipeline momentum. The most dramatic valuation expansion occurred through 2024, when the stock climbed from ~$620 to a peak monthly average near **$906** (around Q3 2024), pushing into the **Fair-to-Watch Interval** territory relative to the then-prevailing PE boundaries. However, a notable correction followed in late 2024 and into 2025, with prices retreating to the $745–$775 range, pulling the stock back toward the **Value Interval**. Encouragingly, a strong recovery emerged in late 2025, with the monthly average surging to over **$1,006–$1,043**, briefly touching the 46.1x boundary (~$944–$1,059), before the most recent data shows a pullback to ~$918. Throughout the entire period, the PE river bands themselves have expanded dramatically — the 26.2x boundary rose from ~$179 in early 2021 to ~$604 by early 2026, and the 46.1x boundary rose from ~$314 to ~$1,059 — confirming sustained and substantial **earnings growth** as the primary driver. Overall, LLY's PE stream chart reflects a company with strong and accelerating profitability, with the stock spending most of its history in the **Value-to-Fair** range, suggesting the market has generally priced it with discipline relative to its earnings power despite the significant price appreciation.